SEC Form 4 · accession 0001624044-16-000008

Syneos Health, Inc. · SYNH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Christopher L Gaenzle

Officer — CAO, GC & Sec

Period of report

Jun 14, 2016

Accepted (ET)

Jun 16, 2016 · 9:03 am EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001610950

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Class A Common Stock	Jun 14, 2016	M	1,946	$16.06	A	18,287	D
Class A Common Stock^F2	Jun 14, 2016	S	1,946	$40.1123	D	16,341	D
Class A Common Stock	Jun 14, 2016	M	1,100	$10.57	A	17,441	D
Class A Common Stock^F3	Jun 14, 2016	S	1,100	$40.052	D	16,341	D
Class A Common Stock	Jun 15, 2016	M	728	$10.57	A	17,069	D
Class A Common Stock^F4	Jun 15, 2016	S	728	$40.215	D	16,341	D
Class A Common Stock	Jun 15, 2016	M	3,928	$16.06	A	20,269	D
Class A Common Stock^F5	Jun 15, 2016	S	3,928	$40.1598	D	16,341	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy Class A Common Stock)^F6	$16.06	Jun 14, 2016	M	1,946	D	—	Jun 30, 2024	Class A Common Stock	1,946	57,225	D
Stock Option (Right to Buy Class A Common Stock)^F7	$10.57	Jun 14, 2016	M	1,100	D	—	Apr 2, 2022	Class A Common Stock	1,100	17,833	D
Stock Option (Right to Buy Class A Common Stock)^F7	$10.57	Jun 15, 2016	M	728	D	—	Apr 2, 2022	Class A Common Stock	728	17,105	D
Stock Option (Right to Buy Class A Common Stock)^F6	$16.06	Jun 15, 2016	M	3,928	D	—	Jun 30, 2024	Class A Common Stock	3,928	53,297	D

Explanation of responses

F1The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2016.
F2The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.31, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.29, inclusive. The reporting person will provide to INC Research Holdings, Inc. (the "Issuer"), any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F4The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $40.12 to $40.31, inclusive. The reporting person will provide to INC Research Holdings, Inc. (the "Issuer"), any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F5The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.38, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F6One half of the shares subject to this option vest yearly in five equal installments beginning on June 30, 2015, subject to continued employment. The other half of the shares subject to this option vest yearly in five equal installments beginning on December 31, 2014, subject to continued employment.
F7One half of the shares subject to this option vest yearly in five equal installments beginning on April 2, 2013, subject to continued employment. The other half of the shares subject to this option vest yearly in five equal installments beginning on December 31, 2013, subject to continued employment.